Effect of cilnidipine, a novel dihydropyridine Ca2+ channel blocker, on adrenal catecholamine secretion in anesthetized dogs.

We investigated the effect of cilnidipine, a novel dihydropyridine Ca2+ channel blocker possessing blocking actions on N-type and L-type voltage-dependent Ca2+ channels (VDCCs), in comparison with the L-type VDCC blocker nifedipine, on adrenal catecholamine secretion in response to splanchnic nerve stimulation (SNS), acetylcholine (ACh), the nicotinic receptor stimulant 1,1-dimethyl-4-phenyl-piperazinium (DMPP), and muscarine in anesthetized dogs. Ca2+ channel blockers and cholinergic agonists were infused and injected, respectively, into the adrenal gland through the phrenicoabdominal artery. Cilnidipine (0.3-3 microg/min) inhibited increases in both epinephrine (EPI) and norepinephrine (NE) output induced by SNS (2 Hz), ACh (1.5 microg), and DMPP (0.2 microg). However, cilnidipine inhibited increase in NE output induced by muscarine (1 microg) without affecting increase in EPI output. Nifedipine (0.3-3 microg/min) inhibited the ACh- and DMPP-induced increases in EPI and NE output without affecting the SNS- and muscarine-induced increases in EPI and NE output. From these results, it seems likely that the inhibition by cilnidipine of the SNS-induced EPI and NE secretion and of the muscarine-induced NE secretion is related to its blocking action on N-type VDCCs.

[1]  T. Nagayama,et al.  Apamin-sensitive SK(Ca) channels modulate adrenal catecholamine release in anesthetized dogs. , 1997, European journal of pharmacology.

[2]  M. Hosono,et al.  Effect of cilnidipine, a novel dihydropyridine Ca++-channel antagonist, on N-type Ca++ channel in rat dorsal root ganglion neurons. , 1997, The Journal of pharmacology and experimental therapeutics.

[3]  H. Ohnishi,et al.  Inhibitory effect of cilnidipine on vascular sympathetic neurotransmission and subsequent vasoconstriction in spontaneously hypertensive rats. , 1995, Japanese journal of pharmacology.

[4]  H. Ohnishi,et al.  Inhibitory effect of cilnidipine on pressor response to acute cold stress in spontaneously hypertensive rats. , 1995, Japanese journal of pharmacology.

[5]  D. O'Connor,et al.  Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension. , 1995, Hypertension.

[6]  S. Satoh,et al.  Inhibition by omega-conotoxin GVIA of adrenal catecholamine release in response to endogenous and exogenous acetylcholine. , 1994, European journal of pharmacology.

[7]  A. Carayon,et al.  Effects of the calcium channel blockers, diltiazem and Ro 40–5967, on systemic haemodynamics and plasma noradrenaline levels in conscious dogs with pacing‐induced heart failure , 1994, British journal of pharmacology.

[8]  T. Shimamura,et al.  Effects of Pirenzepine and Hexamethonium on Adrenal Catecholamine Release in Responses to Endogenous and Exogenous Acetylcholine in Anesthetized Dogs , 1992, Journal of Cardiovascular Pharmacology.

[9]  C. Garland,et al.  Endothelium‐dependent relaxation to acetylcholine in the rabbit basilar artery: importance of membrane hyperpolarization , 1992, British journal of pharmacology.

[10]  M. Inoue,et al.  Muscarinic receptor is coupled with a cation channel through a GTP‐binding protein in guinea‐pig chromaffin cells. , 1991, The Journal of physiology.

[11]  S. Satoh,et al.  Effects of pirenzepine, AF-DX 116 and gallamine on the release of catecholamines from the dog adrenal gland in response to splanchnic nerve stimulation: interaction of M1 and M2 receptors with nicotinic receptors. , 1991, The Journal of pharmacology and experimental therapeutics.

[12]  A. Rittenhouse,et al.  ω‐Conotoxin Inhibits the Acute Activation of Tyrosine Hydroxylase and the Stimulation of Norepinephrine Release by Potassium Depolarization of Sympathetic Nerve Endings , 1991, Journal of neurochemistry.

[13]  M. Sim,et al.  Properties of muscarinic receptors mediating second messenger responses in the rabbit aorta. , 1990, European journal of pharmacology.

[14]  A. Akaike,et al.  Voltage and current clamp studies of muscarinic and nicotinic excitation of the rat adrenal chromaffin cells. , 1990, The Journal of pharmacology and experimental therapeutics.

[15]  M. Oike,et al.  Dual action of FRC8653, a novel dihydropyridine derivative, on the Ba2+ current recorded from the rabbit basilar artery. , 1990, Circulation research.

[16]  H. Teraoka,et al.  Intracellular Ca2+ antagonist TMB-8 blocks catecholamine secretion evoked by caffeine and acetylcholine from perfused cat adrenal glands in the absence of extracellular Ca2+ , 1988, Neuroscience Letters.

[17]  M. Misbahuddin,et al.  Muscarinic stimulation of guinea pig adrenal chromaffin cells stimulates catecholamine secretion without significant increase in Ca2+ uptake , 1988, Neuroscience Letters.

[18]  S. Satoh,et al.  Inhibition by opioid agonists and enhancement by antagonists of the release of catecholamines from the dog adrenal gland in response to splanchnic nerve stimulation: evidence for the functional role of opioid receptors. , 1988, The Journal of pharmacology and experimental therapeutics.

[19]  M. Oleshansky,et al.  Voltage‐independent catecholamine release mediated by the activation of muscarinic receptors in guinea‐pig adrenal glands , 1988, British journal of pharmacology.

[20]  R. Tsien,et al.  Dominant role of N-type Ca2+ channels in evoked release of norepinephrine from sympathetic neurons. , 1988, Science.

[21]  L. Kao,et al.  Calcium Dependence of Muscarinic Receptor‐Mediated Catecholamine Secretion from the Perfused Rat Adrenal Medulla , 1987, Journal of neurochemistry.

[22]  R. Burgoyne,et al.  Effect of activation of muscarinic receptors on intracellular free calcium and secretion in bovine adrenal chromaffin cells. , 1985, Biochimica et biophysica acta.

[23]  N. Hillarp,et al.  Evidence of adrenaline and noradrenaline in separate adrenal medullary cells. , 1953, Acta physiologica Scandinavica.